We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sphere Medical | LSE:SPHR | London | Ordinary Share | GB00B551W951 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.40 | 0.35 | 0.45 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSPHR
RNS Number : 0859R
Sphere Medical Holding plc
19 September 2017
19 September 2017
Sphere Medical Holding plc
("Sphere", "Sphere Medical" or the "Company")
Cancellation of AIM listing
Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, announces that, further to the announcement on 8 September 2017, pursuant to Rule 41 of the AIM Rules for Companies the Company's admission to trading on AIM will be cancelled with effect from 7.00 am BST tomorrow, 20 September 2017.
The capitalised terms used in this announcement have the meaning as defined in the announcement published by the Company at 5:53 p.m. on 21 August 2017 unless otherwise stated.
- Ends -
For further information, please contact:
Hot Features
Premium
Sphere Medical Holding Tel: +44 (0)1223 875
plc 222
Dr Wolfgang Rencken, Chief
Executive Officer
Richard Wright, Chief
Financial Officer
Panmure Gordon Tel: +44 (0) 20 7886
2500
Freddy Crossley (Corporate
Finance)
Duncan Monteith (Corporate
Finance)
Tom Salvesen (Corporate
Broking)
Consilium Strategic Tel: +44 (0) 20 3709
Communications 5700
Mary-Jane Elliott spheremedical@consilium-comms.com
Ivar Milligan
Hendrik Thys
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. For further information, please visit www.spheremedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBLGDCUBBBGRI
(END) Dow Jones Newswires
September 19, 2017 02:00 ET (06:00 GMT)
1 Year Sphere Medical Chart |
1 Month Sphere Medical Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
